Selected Publications

Seif AE, McDonough SL, Oranges KE, Clerico D, Hartman J, Rodock K, Schwartz LA, Elgarten CW, Myers RM, Puszczynski RO, Rheingold SR, Stern JW, Jubelirer TF, Armidea EA, Evangeliou NF, Randall RJ, Bernt KM, Reilly AF, Tasian SK, Diamant RK, Fisher BT, Getz KD, Aplenc R. : AML Care at Home: an evidence-based toolkit to personalize the care setting for recovery from pediatric acute myeloid leukemia chemotherapy. JCO Oncol Pract 2025 (in press).

Zheng DJ, Hettinger G, Bender JD, Boulter AC, Cao L, Elgarten CW, Fisher BT, Gathers C, Huang YV, Ko J, Leger KJ, Li Y, Myers MM, Narayan HK, Ortiz J, Seif SE, Vasileiadi E, Aplenc R, Getz KD: National trends in dexrazoxane and cardiovascular healthcare utilization for children with AML. JAMA Oncol 2025 (in press).

Zheng DJ, Hettinger G, Aftandilian C, Bona K, Caywood EH, Collier AB, Elgarten CW, Gathers C, Ghosh T, Gramatges MM, Henry M, Huang YV, Li Y, Lotterman C, Maloney K, Mian A, Miller TP, Modi A, Mody R, Morgan E, Myers R, Newman H, Ortiz J, Seif AE, Smith C, Stokke J, Wang X, Winick N, Wilkes JJ, Wong V, Aplenc R, Getz KD: Real-world generalizability of clinical trial cytomolecular risk in pediatric acute myeloid leukemia: a report from the REAL-AML cohort. J Natl Cancer Inst Page: Epub ahead of print. Aug 2025.

Wang X, Gimotty PA, Matthews AH, Mamtani R, Luger SM, Hexner EO, Babushok DV, McCurdy SR, Frey NV, Bruno XJ, Gill S, Martin ME, Paralkar VR, Maillard I, Porter DL, Loren AW, Perl AE, Pratz KW, Getz KD*, Lai C*: Evolving racial/ethnic disparities in AML survival in the novel therapy era. Blood Adv. 9(3): 533-544, Feb 2025 Notes: *Dr. Getz and Dr. Lai contributed equally to this study.

Miller TP, Getz KD, Krause E, Jo YG, Charapala S, Gramatages MM, Rabin K, Scheurer ME, Wilkes JJ, Fisher BT, Aplenc R.: Automated Electronic Health Record Data Extraction and Curation Using ExtractEHR. JCO Clin Cancer Inform 8: e2400100, Nov 2024 Notes: doi: 10.1200/CCI.24.00100; Epub 2024 Nov 25.

Zheng DJ†, Hettinger G, Cao L, Elgarten CW, Fisher BT, Gathers C, Huang YV, Ko J, Leger K, Li Y, Myers R, Narayan HK, Ortiz JL, Seif AE, Aplenc A, Getz KD: Near Universal National Uptake of Dexrazoxane in the Real-World Setting Associated with Reduced Cardiac ICU Care Requirements in Pediatric Acute Myeloid Leukemia. Blood 144(Supplement 1): 116, Nov 2024 Notes: Note: Oral presentation at Annual meeting of the American Society of Hematology, December 2024. †Presenter is primary my mentee.

Zheng DJ†, Hettinger G, Aftandilian C, Bona K, Caywood EH, Collier AB, Elgarten CW, Gathers C, Ghosh T, Gramatges MM, Henry M, Huan YV, Li Y, Lotterman C, Maloney K, Mian A, Miller TP, Modi A, Mody R, Morgan E, Myers R, Newman H, Seif AE, Smith C, Stokke J, Winick NJ, Wilkes JJ Wong V, Aplenc A, Getz KD. : Real-World Generalizability of Clinical Trial Cytomolecular Features By Race and Ethnicity in Pediatric Acute Myeloid Leukemia (AML), 2024 annual meeting of the American Society for Hematology. Note: Oral presentation. Blood 144(Supplement 1): 531, Nov 2024 Notes: Note: Oral presentation at Annual meeting of the American Society of Hematology, December 2024. †Presenter is primary my mentee.

Friedes BD, DiNofia AM, Iannone E, Li Y, Rheingold SR, Barz Leahy A, Wray L, Callahan C, Baniewicz D, Vernau L, Getz KD, Aplenc R, Maude SL, Grupp SA, Myers RM: Therapies and outcomes following extramedullary relapse of pediatric and young adult ALL after CD19 CAR T-cell therapy. Blood Adv 28(9): 354-359, Nov 2024 Notes: doi: 10.1182/bloodadvances.2024014518.

Shoag J, Li Y, Getz KD, Huang YS, Hall M, Naranjo A, Richardson T, Desai AV, Umaretiya PJ, Aziz-Bose R, Kelly CA, Zheng DJ, Newman H, Zahler S, Aplenc R, Bagatell R, Bona K.: Healthcare utilization disparities among children with high-risk neuroblastoma treated on Children's Oncology Group clinical trials. Pediatr Blood Cancer 71(10): e31192, Oct 2024 Notes: doi: 10.1002/pbc.31192; Epub 2024 Jul 12.

Oganisian A, Getz KD, Alonzo TA, Aplenc R, Roy JA.: Bayesian semiparametric model for sequential treatment decisions with informative timing. Biostatistics 25(4): 947-961, Oct 2024 Notes: doi: 10.1093/biostatistics/kxad035.